| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.16 | 2e-05 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.16 | 2e-05 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.21 | 5e-05 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0001 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0007 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.093 | 0.002 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.097 | 0.003 |